Medpace will hold its annual shareholder meeting at https://www.virtualshareholdermeeting.com/MEDP2026 on May 15, 2026. Shareholders will vote on electing directors Brian Carley, Femida Gwadry-Sridhar, Robert Kraft, August Troendle and Dani Zander. The meeting will also include a vote to ratify Deloitte and Touche as independent auditor for the fiscal year ending Dec. 31, 2026. Other items include advisory votes on executive compensation and on the frequency of future advisory votes on executive compensation. Shareholders will also vote on amendments to remove supermajority voting requirements and to allow shareholders to call special meetings, and on a shareholder proposal to allow holders of 10% of shares to call a special shareholder meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001668397-26-000008), on March 16, 2026, and is solely responsible for the information contained therein.